These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37332213)

  • 21. Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cells.
    Kozela E; Pietr M; Juknat A; Rimmerman N; Levy R; Vogel Z
    J Biol Chem; 2010 Jan; 285(3):1616-26. PubMed ID: 19910459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Oral Cannabinoids on Systemic Inflammation and Viral Reservoir Markers in People with HIV on Antiretroviral Therapy: Results of the CTN PT028 Pilot Clinical Trial.
    Mboumba Bouassa RS; Comeau E; Alexandrova Y; Pagliuzza A; Yero A; Samarani S; Needham J; Singer J; Lee T; Bobeuf F; Vertzagias C; Sebastiani G; Margolese S; Mandarino E; Klein MB; Lebouché B; Routy JP; Chomont N; Costiniuk CT; Jenabian MA
    Cells; 2023 Jul; 12(14):. PubMed ID: 37508476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.
    De Petrocellis L; Ligresti A; Moriello AS; Allarà M; Bisogno T; Petrosino S; Stott CG; Di Marzo V
    Br J Pharmacol; 2011 Aug; 163(7):1479-94. PubMed ID: 21175579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In Vitro and Clinical Evaluation of Cannabigerol (CBG) Produced via Yeast Biosynthesis: A Cannabinoid with a Broad Range of Anti-Inflammatory and Skin Health-Boosting Properties.
    Perez E; Fernandez JR; Fitzgerald C; Rouzard K; Tamura M; Savile C
    Molecules; 2022 Jan; 27(2):. PubMed ID: 35056807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabinoids Alleviate the LPS-Induced Cytokine Storm via Attenuating NLRP3 Inflammasome Signaling and TYK2-Mediated STAT3 Signaling Pathways In Vitro.
    Suryavanshi SV; Zaiachuk M; Pryimak N; Kovalchuk I; Kovalchuk O
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and tolerability of escalating cannabinoid doses in healthy cats.
    Kulpa JE; Paulionis LJ; Eglit GM; Vaughn DM
    J Feline Med Surg; 2021 Dec; 23(12):1162-1175. PubMed ID: 33769105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Anti-Inflammatory Effects of
    Zaiachuk M; Suryavanshi SV; Pryimak N; Kovalchuk I; Kovalchuk O
    Molecules; 2023 Jun; 28(13):. PubMed ID: 37446655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Could the Combination of Two Non-Psychotropic Cannabinoids Counteract Neuroinflammation? Effectiveness of Cannabidiol Associated with Cannabigerol.
    Mammana S; Cavalli E; Gugliandolo A; Silvestro S; Pollastro F; Bramanti P; Mazzon E
    Medicina (Kaunas); 2019 Nov; 55(11):. PubMed ID: 31752240
    [No Abstract]   [Full Text] [Related]  

  • 29. Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease.
    Martín-Moreno AM; Reigada D; Ramírez BG; Mechoulam R; Innamorato N; Cuadrado A; de Ceballos ML
    Mol Pharmacol; 2011 Jun; 79(6):964-73. PubMed ID: 21350020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential regulation of Ca
    Harding EK; Souza IA; Gandini MA; Gadotti VM; Ali MY; Huang S; Antunes FTT; Trang T; Zamponi GW
    Br J Pharmacol; 2023 Jun; 180(12):1616-1633. PubMed ID: 36647671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabidiol as a treatment for arthritis and joint pain: an exploratory cross-sectional study.
    Frane N; Stapleton E; Iturriaga C; Ganz M; Rasquinha V; Duarte R
    J Cannabis Res; 2022 Aug; 4(1):47. PubMed ID: 35999581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid.
    Massi P; Valenti M; Vaccani A; Gasperi V; Perletti G; Marras E; Fezza F; Maccarrone M; Parolaro D
    J Neurochem; 2008 Feb; 104(4):1091-100. PubMed ID: 18028339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antinociceptive and Immune Effects of Delta-9-Tetrahydrocannabinol or Cannabidiol in Male Versus Female Rats with Persistent Inflammatory Pain.
    Britch SC; Goodman AG; Wiley JL; Pondelick AM; Craft RM
    J Pharmacol Exp Ther; 2020 Jun; 373(3):416-428. PubMed ID: 32179573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
    Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C
    PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals.
    Legare CA; Raup-Konsavage WM; Vrana KE
    Pharmacology; 2022; 107(3-4):131-149. PubMed ID: 35093949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabidiol and Delta-9-Tetrahydrocannabinol Interactions in Male and Female Rats With Persistent Inflammatory Pain.
    Britch SC; Craft RM
    J Pain; 2023 Jan; 24(1):98-111. PubMed ID: 36122809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabidiol prevents chemotherapy-induced neuropathic pain by modulating spinal TLR4 via endocannabinoid system activation.
    Dos Santos R; Veras F; Netto G; Elisei L; Sorgi C; Faccioli L; Galdino G
    J Pharm Pharmacol; 2023 Apr; 75(5):655-665. PubMed ID: 36946366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exosomal delivery of cannabinoids against cancer.
    Kaur S; Nathani A; Singh M
    Cancer Lett; 2023 Jul; 566():216243. PubMed ID: 37257632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT(1A) and CB2 receptors.
    Pazos MR; Mohammed N; Lafuente H; Santos M; Martínez-Pinilla E; Moreno E; Valdizan E; Romero J; Pazos A; Franco R; Hillard CJ; Alvarez FJ; Martínez-Orgado J
    Neuropharmacology; 2013 Aug; 71():282-91. PubMed ID: 23587650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation.
    De Petrocellis L; Orlando P; Moriello AS; Aviello G; Stott C; Izzo AA; Di Marzo V
    Acta Physiol (Oxf); 2012 Feb; 204(2):255-66. PubMed ID: 21726418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.